COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort Study.
Saved in:
| Title: | COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort Study. |
|---|---|
| Authors: | Tan WC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Tan JYJ; Ministry of Health, Singapore., Lim JSJ; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore.; Experimental Therapeutics Programme, Cancer Science Institute, National University of Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Tan RYC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Lee ARYB; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Leong FL; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Lee SC; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore.; Experimental Therapeutics Programme, Cancer Science Institute, National University of Singapore, Singapore., Chai LYA; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore.; Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Synthetic Biology for Clinical and Technological Innovation, National University of Singapore, Singapore., Tan TT; Department of Infectious Diseases, Singapore General Hospital, Singapore., Malek MIBA; Ministry of Health, Singapore., Ong B; Ministry of Health, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Lye DC; Department of Infectious Diseases, Singapore General Hospital, Singapore.; National Centre for Infectious Diseases, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore., Chiew CJ; Ministry of Health, Singapore.; National Centre for Infectious Diseases, Singapore., Chng WJ; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore.; Experimental Therapeutics Programme, Cancer Science Institute, National University of Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Lim ST; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Bharwani LD; Department of Medical Oncology, Tan Tock Seng Hospital, Singapore., Tan IB; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Genome Institute of Singapore, Singapore.; Duke-NUS Medical School, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore., Sundar R; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore.; Singapore Gastric Cancer Consortium, Singapore., Tan KB; Ministry of Health, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore. |
| Source: | JAMA oncology [JAMA Oncol] 2023 Sep 01; Vol. 9 (9), pp. 1221-1229. |
| Publication Type: | Observational Study; Multicenter Study; Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
